RxDoctor Payments Data

Robert Rho

Clinical Cardiac Electrophysiology · Seattle, WANPI 1245354729

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,600 of the $28,536 with a category attached, or 75.7%. Medical Device Business Services, Inc. accounts for 75.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $14,592 and has fallen 73.1% since, to $3,930 in 2025.

$28,536in general payments, 2019–2025

Across 86 payments — averaging $331.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$22K
  • Medtronic$3K
  • Biosense Webster, Inc.$2K
  • Abbott$1K
  • Cardiva Medical, Inc.$99
  • Boston Scientific$39
  • plus $41 from 2 others

What the payments were for

  • Consulting fees$21,60076%
  • Travel & lodging$5,02518%
  • Food & beverage$1,8406%
  • Education$700%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,536 in reported general payments places this provider in the 75th percentile of 68 clinical cardiac electrophysiology providers in Washington.

See all clinical cardiac electrophysiology providers in Washington

Medicare billing

Part B allowed, 2024
$203,725
Medicare patients
269
Services billed
1,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$71,125
MultaqDronedarone Hcl21$13,482
Mexiletine Hcl11$1,750
Ranolazine ErRanolazine36$1,442
Atorvastatin Calcium13$639
Metoprolol Succinate42$598
Amiodarone Hcl31$511
Diltiazem 24hr Er (Cd)Diltiazem Hcl18$313
Carvedilol46$290
Flecainide Acetate17$276
SotalolSotalol Hcl16$226

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →